Autoimmunkrankheiten im HNO-Bereich

  • I. Starek
  • J. Bystron
Chapter
Part of the HNO Praxis heute book series (HNO, volume 20)

Zusammenfassung

Die Gruppe der Autoimmunerkrankungen umfaßt mehr als 80 der heutzutage bekannten klinisch-pathologischen Einheiten und betrifft etwa 20% der gesamten Bevölkerung, vorwiegend jedoch Frauen. Ihre Ätiologie und Pathogenese sind bis zur Gegenwart nicht eindeutig geklärt, trotz der zahlreichen klinischen und experimentellen Studien, die bis auf die geno-molekulare Ebene reichen und auf die Rolle von einigen Viren, Medikamenten sowie genetische Einflüsse hinweisen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adler D, ßröker HJ, Simmling-Annefeld (1981) Rezidivierende Polychondritis. Eine Fallbeschreibung unter besonderer Berücksichtigung der Manifestation im HNO-Bereich. Laryngol Rhinol 69: 187–191CrossRefGoogle Scholar
  2. 2.
    Amaral ALMP, Nascimento AG (1984) Malignant lymphoepithelial lesion of the subman-dibular gland. Oral Surg 58: 184–190PubMedCrossRefGoogle Scholar
  3. 3.
    Andrews J, Koutakis S (1996) Wegener’s granulomatosis of the skull base. Am J Otolaryngol 17: 349–352PubMedCrossRefGoogle Scholar
  4. 4.
    Arnold W, Gebbers JO (1984) Serum Anti-Körper gegen Kornea-und Innenohrgewebe beim Cogan-Syndrom. Z Laryngol Rhinol Otol 63: 428–432CrossRefGoogle Scholar
  5. 5.
    Bachmayer C, Leclerc LN, Laurette F, Coutarel P, Cadranel JF, Médioni J, Dhote R, Mougeot Martin M. (1998) Acute autoimmune hearing loss associated with Crohn’s syndrome. Am J Gastroenterol 93: 2565–2567CrossRefGoogle Scholar
  6. 6.
    Banks PM, Cohen MD, Ginsburg WW, Hunder GG (1983) Immunohistologic and cytochemical studies of temporal arteriitis. Arthritis Rheum 26: 1201–1207PubMedCrossRefGoogle Scholar
  7. 7.
    Barna BP, Hughes GB (1997) Autoimmune inner ear disease — areal entity? Clin Lab Med 17: 581–594PubMedGoogle Scholar
  8. 8.
    Barranco VP, Minor DB, Solomon H (1976) Treatment of relapsing polychondritis with Dapsone. Arch Dermatol 112: 1286–1289PubMedCrossRefGoogle Scholar
  9. 9.
    Bone RC, Fox RI, Howell FV, Fantozzzi R (1985) Sjögren’s syndrome: a persistent clinical problem. Laryngoscope 95: 295–299PubMedCrossRefGoogle Scholar
  10. 10.
    Breedveld FC (1994) Vaseulitis: Mechanisms of injury. Rheumatology in Europe 23: 5Google Scholar
  11. 11.
    Carrie C, Hughes KB, Watson MG (1994) Negative ANCA in Wegener’s granulomatosis. J Laryngol Otol 108: 420–422PubMedGoogle Scholar
  12. 12.
    Cinamon U, Kronenberg J, Hildesheimer M, Taitelbaum R (1997) Cochlear implants in patients suffering from Cogan’s syndrome. J Laryngol Otol 110: 928–930Google Scholar
  13. 13.
    Cogan DG (1945) Syndrome of non-syphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophtalmol 33: 144–149CrossRefGoogle Scholar
  14. 14.
    Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA (1996) The epidemiology of Wegener’s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 39: 87–92PubMedCrossRefGoogle Scholar
  15. 15.
    Chajek T, Fainaru M (1998) Behcet’s disease. Report of 41 cases and review of the literature. Medicine (Baltimore) 54: 179–196Google Scholar
  16. 16.
    Dagum P, Roberson JB (1998) Otologie Wegener’s granulomatosis with facial nerve palsy. Ann Otol Laryngol 107: 555–559Google Scholar
  17. 17.
    Davies SD, Berkmen YM, King T (1989) Peripheral bronchial involvement in relapsing polychondritis: Demonstration by thin-section CT. Am J Radiol 153: 953–954Google Scholar
  18. 18.
    DeRemee R, McDonald T, Harrison E, Coles D (1975) Wegener’s granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc 51: 778–781Google Scholar
  19. 19.
    Devaney KO, Travis WD, Hoffman G, Leavitt R, Lebovics R, Fauci, AS (1990) Interpretation of head and neck biopsies in Wegener’s granulomatosis. A pathologie study of 126 biopsies in 70 patients. Am J Surg Pathol 14: 555–564PubMedCrossRefGoogle Scholar
  20. 20.
    Devaney KO, Ferlito A, Hunter BC (1998) Wegener’s granulomatosis of the head and neck. Ann Otol Laryngol 107: 439–445Google Scholar
  21. 21.
    Dietz A, Hübner C, Andrassy K (1998) Makrolid Antibiotika induzierte Vaskulitis (Churg-Strauss Syndrom). Laryngorhinootologie 77: 111–114PubMedCrossRefGoogle Scholar
  22. 22.
    Duffy FJ, Rossi RM, Pribaz JJ (1998) Reconstruction of Wegener’s nasal deformity using bilateral facial artery musculomucosal flaps. Plast Reconstr Surg 101: 1330–1333PubMedCrossRefGoogle Scholar
  23. 23.
    Ebringer R, Rook G, Swaza T, Bottazzio GF, Doniach D (1981) Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis 40: 473–479PubMedCrossRefGoogle Scholar
  24. 24.
    Eckhardt C (1981) Seltene Form der Augenbeteiligung bei rezidiverender Polychondritis. Klin Mbl Augenheilk 178: 368–372CrossRefGoogle Scholar
  25. 25.
    Eng J, Sabanathan S (1991) Airway complication in relapsing polychondritis. Ann Thorac Surg 51: 686–692PubMedCrossRefGoogle Scholar
  26. 26.
    Estes SA (1983) Relapsing polychondritis. A case report and literature review. Cutis 32: 471–478PubMedGoogle Scholar
  27. 27.
    Fauci AS, Hayness BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis. Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85PubMedGoogle Scholar
  28. 28.
    Fox RI, Robinson C, Curd J, Michelson P, Bone R, Howell FV (1986) First international symposium on Sjögren’s syndrome: Suggested criteria for dassification. Scand J Rheumatol Suppl 61: 28–31PubMedGoogle Scholar
  29. 29.
    Fukase S, Ohta N, Inamura K, Kimura Y, Aoyagi M, Koike Y (1994) Diagnostic specificity of anti-neutrophil cytoplasmatic antibodies (AN CA) in otorhinolaryngological diseases. Acta Otolaryngol (Stock.) Suppl 511: 204–207CrossRefGoogle Scholar
  30. 30.
    Güngor F, Ozdenur F, Tunedemir F, Paksoy N, Karayalcin B, Erkilie M (1997) TC-99 m MDP bone scintigraphy in relapsing polychondritis. Clin Nucl Med 22: 164–266CrossRefGoogle Scholar
  31. 31.
    Harada M, Yoshida H, Mimura Y, Ohishi M, Miyazima I, Ichikawa F, Miyazima Y, Sata M, Tanikawa K (1995) Relapsing polychondritis associated with subclinical Sjögren’s syndrome and phlegmone of the neck. Int Med 34: 768–771CrossRefGoogle Scholar
  32. 32.
    Heimchen C, Jäger L, Bütner U, Reiser M, Brandt T (1998) Cogan’s syndrome. High resolution MRI indicators of activity. J Vestibul Res 8: 155–167CrossRefGoogle Scholar
  33. 33.
    Herman JH (1993) Polychondritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of Rheumatology. Saunders, PhiladelphiaGoogle Scholar
  34. 34.
    Holmes MH, Baethge BA, Abreo F, Wolf RE (1993) Autoimmune exocrinopathy presenting as recurrent parotitis of childhood. Arch Otolaryngol Head Neck Surg 119: 347–349CrossRefGoogle Scholar
  35. 35.
    Hunder GG et al. (1990) The American College of Rheumatology 1990 revised criteria for the classicifation of giant cell arteriitis. Arthritis Rheum 33: 1122–1128PubMedCrossRefGoogle Scholar
  36. 36.
    Cheson BD, Bluming AZ, Alroy J (1976) Cogan’s syndrome: A systemic vasculitis. Am J Med 60: 549–555PubMedCrossRefGoogle Scholar
  37. 37.
    Churg A, Churg J (1998) Steroids and Churg-Strauss syndrome. Lancet 352: 32–33PubMedCrossRefGoogle Scholar
  38. 38.
    Illum P, Thorling K (1982) Otologic manifestations of Wegener’s granulomatosis. Laryngoscope 92: 801–804PubMedCrossRefGoogle Scholar
  39. 39.
    Inamura K, Fukase S, Ohta N, Sakata K, Koike Y (1994) Detection of anti-neutrophil cytoplasmic antibodies (ANCA) using the immunoperoxidase method. Acta Otolaryngol (Stockh.) Suppl 511: 218–220CrossRefGoogle Scholar
  40. 40.
    Jacobs JC (1985) Rheumatology for the practitioner. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  41. 41.
    Kao ChH, Ho YJ, Lan JL, ChangLai Sh P, Chieng PU (1998) Regional cerebral blood flow and glucose metabolism in Sjögren’s syndrome. J Nucl Med 39: 1354–1356PubMedGoogle Scholar
  42. 42.
    Kawamura H, Taniguchi N, Kouichi I, Kano Sh (1990) Salivary gland echography in patients with Sjögren’s syndrome. Arthritis Rheum 33: 505–510PubMedCrossRefGoogle Scholar
  43. 43.
    Kimura T, Nakaoka Y, Yoshida K, Sunami T, Murahashi Y, Hisatsune H, Kuriyama N, Sekikawa S, Kurihara A (1998) Churg-Strauss syndrome diagnosed and followed with gastrointestinal fiberscopic studies and electroneuromyography. Intern Med 37: 646–650PubMedCrossRefGoogle Scholar
  44. 44.
    Klinger H (1931) Grenzformen der Periarteriitis nodosa. Frankf Z Pathol 42: 455–480Google Scholar
  45. 45.
    Krey H (1981) Augenerkrankung bei chronischer atrophischer Polychondritis. Klin Monatsbl Augenheilkd 178: 186–189PubMedCrossRefGoogle Scholar
  46. 46.
    Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese IH, Fries JF, Lie JT, Lightfoot RW, Masi TA, McShane DJ, Mills JA, Stevens MB, Wallace SI, Zvaifler NJ (1990) The Ameriean College of Rheumatology 1990 criteria for the classifieation Churg-Strauss-Syndrome (allergic granulomatosis and angiitis). All Rheum 33: 1094–1110Google Scholar
  47. 47.
    Lie JT (1994) Classification and histopathologic specifity of vasculitis. Rheumatology in Europe 23: 4Google Scholar
  48. 48.
    Luqmani R, Jubb R, Emery P, Reid A, Adu D (1991) Inner ear deafness in Wegener’s granulomatosis. J Rheumatol 18: 766–768PubMedGoogle Scholar
  49. 49.
    Macias JD, Wackym PA, MeGabe BF (1993) Early diagnosis of otologic Wegener’s granulomatosis using the serologic marker C-ANCA. Ann Otol Rhinol Laryngol 102: 337–341PubMedGoogle Scholar
  50. 50.
    Martin J, Roenigk HH, Lymch W, Tingwald FR (1976) Relapsing polychondritis treated with Dapsone. Arch Dermatol 112: 1272–1274PubMedCrossRefGoogle Scholar
  51. 51.
    Mason RM, Barnes CG (1969) Behçet’s syndrome with arthritis. Ann Rheum Dis 28: 95–103PubMedCrossRefGoogle Scholar
  52. 52.
    Matschke RG (1987) Immunologie und Ertaubung. Manifestation der rezidivierenden Polychondritis im HNO-Bereich. Ein Fallbericht. Laryngol Rhinol Otol 66: 337–380Google Scholar
  53. 53.
    McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: Prospective study of 23 patients and review of the literature. Medicine 55: 193–215PubMedCrossRefGoogle Scholar
  54. 54.
    McCaffrey TV, McDonald TI, Facer GW, DeRemee RA (1980) Otologic manifestations of Wegener’s granulomatosis. Otolaryngol Head Neck Surg 88: 586–593PubMedGoogle Scholar
  55. 55.
    McDermott EM, Powell RJ (1998) Cyclosporin in the treatment of Churg-Strauss syndrome. Ann Rheum Dis 57: 257–259CrossRefGoogle Scholar
  56. 56.
    McKee PH (1996) Pathology of the skin. Mosby-Wolfe, London/BaltimoreGoogle Scholar
  57. 57.
    Michet CJ Jr, McKenna CH, Luthra HS, O’Fallon WM (1986) Relapsing polychondritis. Survival and predictive role of early disease manifestation. Ann Intern Med 104: 74–78PubMedGoogle Scholar
  58. 58.
    Narváez I, Valverde GJ, Alerge Sancho JJ, Juanola X, Clavaguera MT, Roig Escofet D (1998) Sudden cochlear hearing loss in a patient with Behçet’s syndrome. Rev Rheum Eng Ed 65: 63–64Google Scholar
  59. 59.
    Novotny M, Litzman J, Polach J, Ovisek P (1992) Immunological profile in Meniere’s disease. Proceedings of the XIXth scientific meeting of the neurootological and equilibriometric society (NES), Bad Kissingen, Germany, 27-29 March. In: Clausen CF, Kirtane M, Schneider D (eds) Medicin + Pharmacie,Dr. Werner Rudat & Co Nachf.,Edition m + p, Hamburg,1994: 577–581Google Scholar
  60. 60.
    O’Duffy J.D (1998) Behçet’s disease. In: Kelley WN, Harris NED Jr, Ruddy S, Sledge CB (eds) Textbook of Rheumatology. Saunders, Philadelphia, pp 1209–1214Google Scholar
  61. 61.
    Ohbayashi N, Yamada I, Yoshino N, Sasaki T (1998) Sjögrens syndrome: Comparison of assessment with MR sialography and conventional sialography. Radiology 209: 683–688PubMedGoogle Scholar
  62. 62.
    Ohyama Y, Nakamura S, Hara H, Shinohara M, Sasaki M, Ikebe-Hiroki A, Mouri T, Tsunawaki S, Abe K, Shirasuna K, Nomota K (1998) Accumulation of human T lymphotrophic virus type I-infected T cells in the salivary glands of patients with human T lymphotropic virus type I-associated Sjögren’s syndrome. Arthritis Rheum 41: 1972–1978PubMedCrossRefGoogle Scholar
  63. 63.
    Okuyama C, Ushijima Y, Sugihara H, Okitsu Sh, Ito H, Tomoho M (1977) Increased subglottic gallium uptake in relapsing polychondritis. J Nucl Med 39: 1977–1199Google Scholar
  64. 64.
    Park JR, Hazleman B (1978) Immunological and histological studies of temporal arteries. Ann Rheum Dis 37: 238–243PubMedCrossRefGoogle Scholar
  65. 65.
    Park JR, Jones JG, Harkiss GD, Hazleman BL (1981) Circulating immune complexes in polymyalgia rheumatica and giant cell arteriitis. Ann Rheum Dis 40: 360–365PubMedCrossRefGoogle Scholar
  66. 66.
    Rarey KE, Bicknell JM, Davies LE (1986) Intralabyrinthine osteogenesis in Cogan’s syndrome. Am J Otolaryngol 4: 387–390CrossRefGoogle Scholar
  67. 67.
    Reiss M (1998) Cogan syndrome’ a case report. Schweiz Rundsch Med Prax 87: 1105–1108Google Scholar
  68. 68.
    Rigby S, Griffiths D.J, Weiss KA, Venables PJW (1997) Human retrovirus-5 proviral DNA is rarely detected in salivary gland biopsy tissues from patients with Sjögren”s syndrome. Arthritis Rheum 40: 2016–2121PubMedCrossRefGoogle Scholar
  69. 69.
    Rotem M, Fauci A, Hallahan C, Kerr G, Lebovics R, Leavitt R, Hoffman G (1993) Wegener’s granulomatosis in children and adolescents: Clinical presentation and outcome. J Pediatr 122: 26–31CrossRefGoogle Scholar
  70. 70.
    Schlapbach V, Im Hof V (1988) Rezidivierende Polychondritis: Eine schillernde Erkrankung. Schweiz Med Wochenschr 118: 535–340PubMedGoogle Scholar
  71. 71.
    St. Clair EW, McCallum BM (1999) Cogan’s syndrome. Curr Opin Rheumatol 11: 47–52PubMedCrossRefGoogle Scholar
  72. 72.
    Trentham DE, Lee CH (1998) Relapsing polychondritis Ann Intern Med 129: 114–122PubMedGoogle Scholar
  73. 73.
    Trittel C, Möller J, Euler HH, Werner JA (1995) Das Churg-Strauss-Syndrom — eine Differentialdiagnose bei chronisch polypöser Sinusitis. Laryngorhinootologie 74: 577–580PubMedCrossRefGoogle Scholar
  74. 74.
    Vanoli M, Bambini D, Scorza R (1998) A case of Churg-Strauss vasculitis after hepatitis B vaccination. Ann Rheum Dis 57: 256–257PubMedCrossRefGoogle Scholar
  75. 75.
    Veldman JE (1997) Immune-mediated sensorineural loss with or without endolymphatic hydrops: a clinical and experimental approach. Ann NY Acad Sci 830: 179–186PubMedCrossRefGoogle Scholar
  76. 76.
    Wallesch B, Kleinsasser O (1990) Trachealstenosen als erstes Symptom einer Panchondropathie. Laryngorhinootologie 69: 561–563PubMedCrossRefGoogle Scholar
  77. 77.
    Wegener F (1936) Über generalisierte, septische Gefässerkrankungen. Verh Dtsch Ges Pathol 29: 202–210Google Scholar
  78. 78.
    Wegener F (1939) Über eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Pathol 102: 36–38Google Scholar
  79. 79.
    West PDB (1988) Relapsing polychondritis: An unusual presentation. J Laryngol Otol 102: 254–255PubMedCrossRefGoogle Scholar
  80. 80.
    Wolff D, Bernhard WG, Tsutsumi S, Ross IS, Nussbaum HE (1965) The pathology of Cogan’s syndrome causing profound deafness. Ann Otol 74: 507–520Google Scholar
  81. 81.
    Wortmann DW, Nelson AM (1990) Kawasaki syndrome. Rheum Dis Clin North Am 16: 363–375PubMedGoogle Scholar
  82. 82.
    Wright V, Chamberlain A (1978) Behçet’s syndrome. Bull Rheum Dis 29: 972–977PubMedGoogle Scholar
  83. 83.
    Yoo TJ, Stuart JM, Kang AH, Townes AS, Tomoda K, Dixit S (1982) Type II collagen auto-immunity in otosclerosis and Meniere’s disease. Science: 1153–1155Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • I. Starek
  • J. Bystron

There are no affiliations available

Personalised recommendations